Programme 17004 · MFT / MPT

MSc in Biopharmaceutical Development and Commercialization

The flagship route. One intensive year in Hong Kong learning how modern therapies are engineered, approved, priced and brought to market.

1 yrFull-time
2 yrPart-time
31Credits
MixedMode of study
At a glance

The essentials

Everything you need to judge whether this route fits your plans, your timetable and your budget.

Programme title
Master of Science in Biopharmaceutical Development and Commercialization
Programme code
17004 — stream codes MFT (full-time) and MPT (part-time)
Normal duration
1 year full-time · 2 years part-time
Mode of study
Mixed mode
Credits for graduation
31 credits
Credits on initial registration
Local full-time 9 · local part-time 6 · non-local 12 (both modes)
Tuition fee
HK$8,400 per credit — the same rate for local and non-local students
Entrance year
September 2027
Programme leader
Prof. Wong Tsun-ting, Clarence (PhD)
Deputy programme leader
Prof. Ko Chi-bun, Ben (PhD)
Entry requirements
Bachelor's degree in life/biological sciences, chemistry, biomedical sciences/engineering, health science or a related discipline. See details ↓

Entrance requirements are published in full on the official PolyU programme page — check them before you apply. Official page →

Admission

Entry requirements

A Bachelor's degree or the equivalent in biological/life sciences, chemistry, biomedical sciences/engineering, health science, or a related discipline.

Please refer to the Admission Requirements section for details.

Curriculum

Four pillars, one commercial mindset

The curriculum integrates the scientific, business, regulatory and ethical aspects of the biopharmaceutical landscape.

🧬

Advanced therapeutics

Biologics and protein engineering through to cell and gene therapies — how today's most complex medicines are designed and produced.

⚖️

Regulation & approval

Clinical trial design and the drug approval process: what regulators expect, and how evidence is built to satisfy them.

🔐

Patents & IP strategy

Patenting strategies that protect an asset, define freedom to operate and underpin every licensing conversation.

📈

Market entry & pricing

Commercial acumen — positioning, pricing and the route a therapy takes from approval to real patients.

Subject by subject

What you'll actually study

Seven core subjects, plus what's unique to the Hong Kong route.

Core subjects Taught on every MSc BDC route
ABCT5T01Academic Integrity and Ethics in ScienceUniversity requirement
ABCT5103Intellectual Property Strategy for Biotech Entrepreneurship
ABCT5104Regulatory Science for Biotech Products
ABCT5105Ethics and Management in Life Sciences
ABCT5106Technology Platforms in Drug Discovery
ABCT5107Advanced Therapeutic Products
ABCT5108 / ABCT5109 Investment Financing and Risk Management in Biobusiness or Entrepreneurship: From Lab to Launch Choose 1 of 2
Plus on this route Only on the Hong Kong programme
ABCT5101Modern Approaches in Biopharmaceutical Development
ABCT5102Pharmacology and Toxicology in Biotherapeutics
Optional core 6 credits — choose one of two paths
ABCT5110 / ABCT5113 Industrial Attachment (6) or Research Project (6) Choose 1 of 2

Industrial Attachment — roughly 400 hours on placement. The department lists openings in a range of countries, and you may also source your own; either way, you interview and secure the position yourself.
Research Project — you approach a PolyU professor to supervise you, then spend six months on a hands-on project in their group. If you're aiming at a PhD, this gives genuine research experience to draw on — but it is research training only, not a PhD placement, with no commitment from the supervisor beyond the project.

Subject list follows the official curriculum page. Official curriculum page → Subject offerings are subject to change — confirm with the department before applying.

Learning outcomes

What you'll be able to do

Graduates leave fluent in both halves of the industry conversation — able to hold their own with a research team in the morning and a commercial board in the afternoon.

  • Scientific proficiency in cutting-edge therapeutic modalities.
  • Commercial acumen covering market entry and pricing decisions.
  • Regulatory expertise spanning trials, approval and compliance.
  • Interdisciplinary collaboration across science, law and business teams.

Where graduates go

The skill set maps directly onto the roles biopharma companies struggle to fill:

Regulatory affairsClinical operationsBusiness development Market accessProduct managementIP & licensing Biotech venture rolesMedical affairs
Admissions

Apply in two rounds

Early applications are strongly encouraged — places are limited and offers are made on a competitive basis.

Start your application
Early round

20 October 2026

Recommended. Widest choice of places and earliest decisions.

Main round

25 February 2027

Remaining places offered competitively.

Entry

September 2027

Studies begin at PolyU, Hung Hom, Hong Kong.

Also consider

The other two routes

Questions?

Talk to the programme team.

Want to know more about the programme, please contact us.